Tsukuba, Japan

Syuji Hinuma


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 35(Granted Patents)


Location History:

  • Tsukuba, JP (2008)
  • Ibaraki, JP (2008)

Company Filing History:


Years Active: 2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Syuji Hinuma: Innovator in Peptide Research

Introduction

Syuji Hinuma is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of peptide research, particularly in the development of novel peptides and their applications in medicine. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Hinuma's latest patents include "Isolated physiologically active peptide and use thereof" and a method for screening compounds that interact with G protein-coupled receptors. The first patent focuses on providing a novel peptide and its encoding DNA, which can be utilized for diagnosing and treating digestive diseases. The invention also includes a drug comprising the peptide or DNA, as well as a screening method for compounds that can promote or inhibit the peptide's activity. The second patent outlines a screening method for identifying agonists and antagonists that alter the binding properties of a specific receptor protein related to cholesterol metabolism.

Career Highlights

Syuji Hinuma is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research in peptide technology. His work is characterized by a commitment to innovation and the development of therapeutic solutions that address critical health issues.

Collaborations

Hinuma has collaborated with notable colleagues, including Tetsuya Ohtaki and Yasushi Masuda. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Syuji Hinuma's contributions to peptide research exemplify the importance of innovation in the medical field. His patents and ongoing work at Takeda Pharmaceutical Company Limited highlight his dedication to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…